title: NICE recommendations: why no disinvestment recommendations to offset investment decisions?
authors.affiliation: Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor LL57 2PZ, UK d.a.hughes@bangor.ac.uk.
authors.forename: Dyfrig A
authors.initials: DA
authors.lastname: Hughes
authors.affiliation: Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor LL57 2PZ, UK.
authors.forename: Eifiona M
authors.initials: EM
authors.lastname: Wood
authors.affiliation: Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor LL57 2PZ, UK.
authors.forename: Lorna
authors.initials: L
authors.lastname: Tuersley
mesh_terms: D020811:Biomedical Technology / Q000191:economics*; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D004739:England; D006801:Humans; D013222:State Medicine; D014852:Wales